Literature DB >> 11997508

Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms.

Nicolas Dumaz1, Yvonne Light, Richard Marais.   

Abstract

It is widely accepted that cyclic AMP (cAMP) can block cell growth by phosphorylating Raf-1 on serine 43 and inhibiting signaling to extracellular signal-regulated protein kinase. We show that the suppression of Raf-1 by cAMP is considerably more complex than previously reported. When cellular cAMP is elevated, Raf-1 is phosphorylated on three residues (S43, S233, and S259), which work independently to block Raf-1. Both Ras-dependent and Ras-independent processes are disrupted. However, when cAMP-insensitive versions of Raf-1 are expressed in NIH 3T3 cells, their growth is still strongly suppressed when cAMP is elevated. Thus, although Raf-1 appears to be an important cAMP target, other pathways are also targeted by cAMP, providing alternative mechanisms that lead to suppression of cell growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997508      PMCID: PMC133826          DOI: 10.1128/MCB.22.11.3717-3728.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases.

Authors:  F R McKenzie; J Pouysségur
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

2.  Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras.

Authors:  J de Rooij; J L Bos
Journal:  Oncogene       Date:  1997-02-06       Impact factor: 9.867

3.  Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases.

Authors:  R Marais; Y Light; H F Paterson; C S Mason; C J Marshall
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

4.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

Review 5.  Ras-Raf complexes: analyses of complexes formed in vivo.

Authors:  R Finney; D Herrera
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

6.  Negative regulation of Raf-1 by phosphorylation of serine 621.

Authors:  H Mischak; T Seitz; P Janosch; M Eulitz; H Steen; M Schellerer; A Philipp; W Kolch
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination.

Authors:  R Marais; R A Spooner; Y Light; J Martin; C J Springer
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

8.  Identification of the major phosphorylation sites of the Raf-1 kinase.

Authors:  D K Morrison; G Heidecker; U R Rapp; T D Copeland
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

9.  Mechanism of inhibition of Raf-1 by protein kinase A.

Authors:  S Häfner; H S Adler; H Mischak; P Janosch; G Heidecker; A Wolfman; S Pippig; M Lohse; M Ueffing; W Kolch
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

10.  Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.

Authors:  R Marais; Y Light; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

View more
  23 in total

1.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

2.  Inducible gene deletion reveals different roles for B-Raf and Raf-1 in B-cell antigen receptor signalling.

Authors:  Tilman Brummer; Peter E Shaw; Michael Reth; Yukiko Misawa
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Authors:  J Delyon; A Servy; F Laugier; J André; N Ortonne; M Battistella; S Mourah; A Bensussan; C Lebbé; N Dumaz
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

4.  MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells.

Authors:  Jesse Lyons; Boris C Bastian; Frank McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-01       Impact factor: 11.205

5.  Integrated proteome and HPLC analysis revealed quercetin-mediated inhibition of aflatoxin B1 biosynthesis in Aspergillus flavus.

Authors:  Shraddha Tiwari; Jata Shankar
Journal:  3 Biotech       Date:  2018-01-03       Impact factor: 2.406

Review 6.  NRAS mutant melanoma: biological behavior and future strategies for therapeutic management.

Authors:  I V Fedorenko; G T Gibney; K S M Smalley
Journal:  Oncogene       Date:  2012-10-15       Impact factor: 9.867

7.  Galectin-8 induces apoptosis in Jurkat T cells by phosphatidic acid-mediated ERK1/2 activation supported by protein kinase A down-regulation.

Authors:  Andrés Norambuena; Claudia Metz; Lucas Vicuña; Antonia Silva; Evelyn Pardo; Claudia Oyanadel; Loreto Massardo; Alfonso González; Andrea Soza
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

8.  Integrated modulation of phorbol ester-induced Raf activation in EL4 lymphoma cells.

Authors:  Shujie Han; Kathryn E Meier
Journal:  Cell Signal       Date:  2009-01-19       Impact factor: 4.315

9.  Potentiation of carbachol-induced detrusor smooth muscle contractions by beta-adrenoceptor activation.

Authors:  Adam P Klausner; Keith F Rourke; Amy S Miner; Paul H Ratz
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

10.  Ras-mutant cancer cells display B-Raf binding to Ras that activates extracellular signal-regulated kinase and is inhibited by protein kinase A phosphorylation.

Authors:  Yanping Li; Maho Takahashi; Philip J S Stork
Journal:  J Biol Chem       Date:  2013-07-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.